Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
6,110.00
+190.00 (3.21%)
May 21, 2026, 11:49 AM KST
-36.15% (1Y)
| Market Cap | 137.68B -27.6% |
| Revenue (ttm) | n/a +13,737.3% |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 23.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 43,570 |
| Average Volume | 151,174 |
| Open | 5,920.00 |
| Previous Close | 5,920.00 |
| Day's Range | 5,920.00 - 6,170.00 |
| 52-Week Range | 5,910.00 - 11,520.00 |
| Beta | 0.82 |
| RSI | 19.78 |
| Earnings Date | n/a |